Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-23-002481

COO and General Counsel sold 15,000 shares at $37.39 ($560,850)

From the SEC's structured data for this filing

Trades in this filing

O'Brien Patrick · COO and General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-05 Sale : show line 1 in the form −7,500 $37.39 $280,425 420,875 D
2023-01-05 Sale : show line 2 in the form −7,500 $37.39 $280,425 413,375 D
Open-market sales · 15,000 sh · avg $37.39 · $560,850
Loading xslF345X03/doc4.xml…